Citations (35)
Keep up to date with the latest research on this topic with citation updates for this article.
Articles from other publishers (35)
Masafumi Funamoto, Masaki Imanishi, Koichiro Tsuchiya & Yasumasa Ikeda. (2023) Roles of histone acetylation sites in cardiac hypertrophy and heart failure. Frontiers in Cardiovascular Medicine 10.
Crossref
Crossref
Santosh K Sanganalmath, Shubham Dubey, Sudhakar Veeranki, Keerthy Narisetty & Prasanna Krishnamurthy. (2023) The interplay of inflammation, exosomes and Ca2+ dynamics in diabetic cardiomyopathy. Cardiovascular Diabetology 22:1.
Crossref
Crossref
Fernando Lizcano & Lizeth Bustamante. (2022) Molecular perspectives in hypertrophic heart disease: An epigenetic approach from chromatin modification. Frontiers in Cell and Developmental Biology 10.
Crossref
Crossref
Youwei Zheng, Xinchao Li, Lirun Kuang & Yong Wang. (2022) New insights into the characteristics of DRAK2 and its role in apoptosis: From molecular mechanisms to clinically applied potential. Frontiers in Pharmacology 13.
Crossref
Crossref
Supaporn Kulthinee, Naohiro Yano, Shougang Zhuang, Lijiang Wang & Ting C. Zhao. (2022) Critical Functions of Histone Deacetylases (HDACs) in Modulating Inflammation Associated with Cardiovascular Diseases. Pathophysiology 29:3, pages 471-486.
Crossref
Crossref
Yu Han, Jiali Nie, Dao Wen Wang & Li Ni. (2022) Mechanism of histone deacetylases in cardiac hypertrophy and its therapeutic inhibitors. Frontiers in Cardiovascular Medicine 9.
Crossref
Crossref
Kathryn G. Helmstadter, Senka Ljubojevic-Holzer, Brent M. Wood, Khanha D. Taheri, Simon Sedej, Jeffrey R. Erickson, Julie Bossuyt & Donald M. Bers. (2021) CaMKII and PKA-dependent phosphorylation co-regulate nuclear localization of HDAC4 in adult cardiomyocytes. Basic Research in Cardiology 116:1.
Crossref
Crossref
Rokas Miksiunas, Ruta Aldonyte, Agne Vailionyte, Tadas Jelinskas, Romuald Eimont, Gintare Stankeviciene, Vytautas Cepla, Ramunas Valiokas, Kestutis Rucinskas, Vilius Janusauskas, Siegfried Labeit & Daiva Bironaite. (2021) Cardiomyogenic Differentiation Potential of Human Dilated Myocardium-Derived Mesenchymal Stem/Stromal Cells: The Impact of HDAC Inhibitor SAHA and Biomimetic Matrices. International Journal of Molecular Sciences 22:23, pages 12702.
Crossref
Crossref
Dhirendra Singh & Sumeet Gupta. (2021) Butyrate: A Review on Beneficial Pharmacological and Therapeutic Effect. Current Nutrition & Food Science 17:5, pages 470-482.
Crossref
Crossref
Lorrayny G Silva, Bradley S Ferguson, Andre S Avila & Antonio P Faciola. (2018) Sodium propionate and sodium butyrate effects on histone deacetylase (HDAC) activity, histone acetylation, and inflammatory gene expression in bovine mammary epithelial cells1. Journal of Animal Science.
Crossref
Crossref
Izabela Piotrowska, Mark Isalan & Michal Mielcarek. (2017) Early transcriptional alteration of histone deacetylases in a murine model of doxorubicin-induced cardiomyopathy. PLOS ONE 12:6, pages e0180571.
Crossref
Crossref
Hermann A.M. Mucke. (2017) Drug Repurposing Patent Applications October–December 2016. ASSAY and Drug Development Technologies 15:3, pages 120-126.
Crossref
Crossref
Deli Zhang, Xu Hu, Robert H. Henning & Bianca J.J.M. Brundel. (2016) Keeping up the balance: role of HDACs in cardiac proteostasis and therapeutic implications for atrial fibrillation. Cardiovascular Research 109:4, pages 519-526.
Crossref
Crossref
Mengwen Yan, Chen Chen, Wei Gong, Zhongwei Yin, Ling Zhou, Sandip Chaugai & Dao Wen Wang. (2015) miR-21-3p regulates cardiac hypertrophic response by targeting histone deacetylase-8. Cardiovascular Research 105:3, pages 340-352.
Crossref
Crossref
Michal Mielcarek, Marie K. Bondulich, Linda Inuabasi, Sophie A. Franklin, Thomas Muller & Gillian P. Bates. (2014) The Huntington's Disease-Related Cardiomyopathy Prevents a Hypertrophic Response in the R6/2 Mouse Model. PLoS ONE 9:9, pages e108961.
Crossref
Crossref
Kelly A. Hyndman, Dao H. Ho, Martiana F. Sega & Jennifer S. Pollock. (2014) Histone deacetylase 1 reduces NO production in endothelial cells via lysine deacetylation of NO synthase 3. American Journal of Physiology-Heart and Circulatory Physiology 307:5, pages H803-H809.
Crossref
Crossref
Gwang Hyeon Eom & Hyun Kook. (2014) Posttranslational modifications of histone deacetylases: Implications for cardiovascular diseases. Pharmacology & Therapeutics 143:2, pages 168-180.
Crossref
Crossref
Deli ZhangChia-Tung WuXiaoYan QiRoelien A.M. MeijeringFemke Hoogstra-BerendsArtavazd TadevosyanGunseli Cubukcuoglu DenizSerkan DurduAhmet Ruchan AkarOdy C.M. SibonStanley NattelRobert H. HenningBianca J.J.M. Brundel. (2014) Activation of Histone Deacetylase-6 Induces Contractile Dysfunction Through Derailment of α-Tubulin Proteostasis in Experimental and Human Atrial Fibrillation. Circulation 129:3, pages 346-358.
Crossref
Crossref
Young Jun Seo. (2013) Thiophene-derivatized Fluorescent Benzamides as Possible Probes for Histone Deacetylases. Bulletin of the Korean Chemical Society 34:8, pages 2249-2250.
Crossref
Crossref
Angela Ramjiawan, Rushita A. Bagchi, Alexandra Blant, Laura Albak, Maria A. Cavasin, Todd R. Horn, Timothy A. McKinsey & Michael P. Czubryt. (2013)
Roles of histone deacetylation and AMP kinase in regulation of cardiomyocyte
PGC-1α
gene expression in hypoxia
. American Journal of Physiology-Cell Physiology 304:11, pages C1064-C1072.
Crossref
Crossref
Frédéric Thuaud, Nigel Ribeiro, Canan G. Nebigil & Laurent Désaubry. (2013) Prohibitin Ligands in Cell Death and Survival: Mode of Action and Therapeutic Potential. Chemistry & Biology 20:3, pages 316-331.
Crossref
Crossref
Chia-Wei Jenny Chang, Linda Lee, David Yu, Khanha Dao, Julie Bossuyt & Donald M. Bers. (2013) Acute β-Adrenergic Activation Triggers Nuclear Import of Histone Deacetylase 5 and Delays Gq-induced Transcriptional Activation. Journal of Biological Chemistry 288:1, pages 192-204.
Crossref
Crossref
Nigel Ribeiro, Frédéric Thuaud, Yohann Bernard, Christian Gaiddon, Thierry Cresteil, Audrey Hild, Etienne C. Hirsch, Patrick Pierre Michel, Canan G. Nebigil & Laurent Désaubry. (2012) Flavaglines as Potent Anticancer and Cytoprotective Agents. Journal of Medicinal Chemistry 55:22, pages 10064-10073.
Crossref
Crossref
Tatsuya Usui, Muneyoshi Okada, Wataru Mizuno, Mayuko Oda, Natsuki Ide, Tomoka Morita, Yukio Hara & Hideyuki Yamawaki. (2012) HDAC4 mediates development of hypertension via vascular inflammation in spontaneous hypertensive rats. American Journal of Physiology-Heart and Circulatory Physiology 302:9, pages H1894-H1904.
Crossref
Crossref
Abishek Iyer, David P Fairlie & Lindsay Brown. (2011) Lysine acetylation in obesity, diabetes and metabolic disease. Immunology & Cell Biology 90:1, pages 39-46.
Crossref
Crossref
H.F. Duncan, A.J. Smith, G.J.P. Fleming & P.R. Cooper. (2011) HDACi. Journal of Dental Research 90:12, pages 1377-1388.
Crossref
Crossref
Joost J. Leenders, Yigal M. Pinto & Esther E. Creemers. (2011) Tapping the brake on cardiac growth-endogenous repressors of hypertrophic signaling-. Journal of Molecular and Cellular Cardiology 51:2, pages 156-167.
Crossref
Crossref
Mazen Kurdi & George W. Booz. (2011) Three 4-letter words of hypertension-related cardiac hypertrophy: TRPC, mTOR, and HDAC. Journal of Molecular and Cellular Cardiology 50:6, pages 964-971.
Crossref
Crossref
Shu-Kuan Ling, Rui Wang, Zhong-Quan Dai, Jie-Lin Nie, Hong-Hui Wang, Ying-Jun Tan, Hong-Qing Cao, Zeng-Ming Huang, Yu-Min Wan & Ying-Hui Li. (2011) Pretreatment of rat bone marrow mesenchymal stem cells with a combination of hypergravity and 5-azacytidine enhances therapeutic efficacy for myocardial infarction. Biotechnology Progress 27:2, pages 473-482.
Crossref
Crossref
Vincenzo Lionetti, Giacomo Bianchi, Fabio A. Recchia & Carlo Ventura. (2010) Control of autocrine and paracrine myocardial signals: an emerging therapeutic strategy in heart failure. Heart Failure Reviews 15:6, pages 531-542.
Crossref
Crossref
Jonathan A. Epstein. (2010) Cardiac Development and Implications for Heart Disease. New England Journal of Medicine 363:17, pages 1638-1647.
Crossref
Crossref
Bianca C. Bernardo, Kate L. Weeks, Lynette Pretorius & Julie R. McMullen. (2010) Molecular distinction between physiological and pathological cardiac hypertrophy: Experimental findings and therapeutic strategies. Pharmacology & Therapeutics 128:1, pages 191-227.
Crossref
Crossref
Jeffrey P. CardinaleSrinivas SriramulaRomain PariautAnuradha GuggilamNithya MariappanCarrie M. ElksJoseph Francis. (2010) HDAC Inhibition Attenuates Inflammatory, Hypertrophic, and Hypertensive Responses in Spontaneously Hypertensive Rats. Hypertension 56:3, pages 437-444.
Crossref
Crossref
Junya Kuroda & Junichi Sadoshima. (2010) NADPH Oxidase and Cardiac Failure. Journal of Cardiovascular Translational Research 3:4, pages 314-320.
Crossref
Crossref
Claudia Colussi, Barbara Illi, Jessica Rosati, Francesco Spallotta, Antonella Farsetti, Annalisa Grasselli, Antonello Mai, Maurizio C. Capogrossi & Carlo Gaetano. (2010) Histone deacetylase inhibitors: Keeping momentum for neuromuscular and cardiovascular diseases treatment. Pharmacological Research 62:1, pages 3-10.
Crossref
Crossref